April 11, 2018 / 8:10 AM / 12 days ago

BRIEF-Zhenxing Biopharmaceutical & Chemical unit receives approval for drug clinical trial

April 11(Reuters) - Zhenxing Biopharmaceutical & Chemical Co Ltd

* Says co’s Guangdong-based wholly owned biopharmaceutical unit received approval for drug clinical trial for Human Fibrinogen, from China Food and Drug Administration

Source text in Chinese: goo.gl/9eN1Q8

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below